Cargando…
Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures?
Bipolar disorder (BD) is a relevant public health issue, therefore accurate screening tools could be useful. The objective of this study is to verify the accuracy of the Mood Disorder Questionnaire (MDQ) and genetic risk as screeners, and their comparison in terms of reliability. Older adults (N = 6...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453758/ https://www.ncbi.nlm.nih.gov/pubmed/37623258 http://dx.doi.org/10.3390/clinpract13040077 |
_version_ | 1785096018352668672 |
---|---|
author | Carta, Mauro Giovanni Kalcev, Goce Scano, Alessandra Pinna, Samantha Gonzalez, Cesar Ivan Aviles Nardi, Antonio Egidio Orrù, Germano Primavera, Diego |
author_facet | Carta, Mauro Giovanni Kalcev, Goce Scano, Alessandra Pinna, Samantha Gonzalez, Cesar Ivan Aviles Nardi, Antonio Egidio Orrù, Germano Primavera, Diego |
author_sort | Carta, Mauro Giovanni |
collection | PubMed |
description | Bipolar disorder (BD) is a relevant public health issue, therefore accurate screening tools could be useful. The objective of this study is to verify the accuracy of the Mood Disorder Questionnaire (MDQ) and genetic risk as screeners, and their comparison in terms of reliability. Older adults (N = 61, ≥60 years) received a clinical psychiatric evaluation, the MDQ, and were evaluated according to the presence of the genetic variant RS1006737 of CACNA1C. MDQ+ versus the diagnosis of BD as a gold standard shows a sensitivity of 0.286 (Cl 95% 0.14–0.39); a specificity of 0.925 (Cl 95% 0.85–0.08); a predictive positive value (PPV) of 0.667 (Cl 95% 0.33–0.91); and a predictive negative value (PNV) of 0.702 (Cl 95% 0.65–0.75). The positivity for the variant RS1006737 of the CACNA1C against the diagnosis of BD as a gold standard shows a sensitivity of 0.750 (Cl 95% 0.55–0.90); a specificity of 0.375 (Cl 95% 0.28–0.45); a PPV of 0.375 (Cl 95% 0.28–0.45); and a PNV of 0.750 (Cl 95% 0.55–0.90). The reliability between the MDQ+ and positivity for the variant RS1006737 of the CACNA1C was very low (K = −0.048, Cl 95% −0.20–0.09). The study found that both the genetic and the paper and pencil test were quite accurate, but were not reliable in case finding. In fact, despite some validity, albeit specular (in the case of a positive genetic test, the probability of having the disorder is very high, whereas in the case of a negative score on the paper and pencil test, the probability of not having the disorder is very high), the unreliability of the two tests (i.e., they certainly do not measure the same underlying dimension) opens the door to the need for an interpretation and the possibility of a synergistic use for screening. From a heuristic perspective, which obviously requires all of the necessary verifications, this study seems to suggest the hypothesis that a condition of hyperactivation common to disorders and stress conditions, and identified by a positive score on the MDQ (which is common to BD, post-traumatic stress disorder (PTSD), and anxiety disorders and whose genetic basis has not yet been clarified) can trigger BD in people with a predisposition to hyperactivity (i.e., in people with the condition identified by the analyzed genetic variant). |
format | Online Article Text |
id | pubmed-10453758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104537582023-08-26 Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures? Carta, Mauro Giovanni Kalcev, Goce Scano, Alessandra Pinna, Samantha Gonzalez, Cesar Ivan Aviles Nardi, Antonio Egidio Orrù, Germano Primavera, Diego Clin Pract Article Bipolar disorder (BD) is a relevant public health issue, therefore accurate screening tools could be useful. The objective of this study is to verify the accuracy of the Mood Disorder Questionnaire (MDQ) and genetic risk as screeners, and their comparison in terms of reliability. Older adults (N = 61, ≥60 years) received a clinical psychiatric evaluation, the MDQ, and were evaluated according to the presence of the genetic variant RS1006737 of CACNA1C. MDQ+ versus the diagnosis of BD as a gold standard shows a sensitivity of 0.286 (Cl 95% 0.14–0.39); a specificity of 0.925 (Cl 95% 0.85–0.08); a predictive positive value (PPV) of 0.667 (Cl 95% 0.33–0.91); and a predictive negative value (PNV) of 0.702 (Cl 95% 0.65–0.75). The positivity for the variant RS1006737 of the CACNA1C against the diagnosis of BD as a gold standard shows a sensitivity of 0.750 (Cl 95% 0.55–0.90); a specificity of 0.375 (Cl 95% 0.28–0.45); a PPV of 0.375 (Cl 95% 0.28–0.45); and a PNV of 0.750 (Cl 95% 0.55–0.90). The reliability between the MDQ+ and positivity for the variant RS1006737 of the CACNA1C was very low (K = −0.048, Cl 95% −0.20–0.09). The study found that both the genetic and the paper and pencil test were quite accurate, but were not reliable in case finding. In fact, despite some validity, albeit specular (in the case of a positive genetic test, the probability of having the disorder is very high, whereas in the case of a negative score on the paper and pencil test, the probability of not having the disorder is very high), the unreliability of the two tests (i.e., they certainly do not measure the same underlying dimension) opens the door to the need for an interpretation and the possibility of a synergistic use for screening. From a heuristic perspective, which obviously requires all of the necessary verifications, this study seems to suggest the hypothesis that a condition of hyperactivation common to disorders and stress conditions, and identified by a positive score on the MDQ (which is common to BD, post-traumatic stress disorder (PTSD), and anxiety disorders and whose genetic basis has not yet been clarified) can trigger BD in people with a predisposition to hyperactivity (i.e., in people with the condition identified by the analyzed genetic variant). MDPI 2023-07-27 /pmc/articles/PMC10453758/ /pubmed/37623258 http://dx.doi.org/10.3390/clinpract13040077 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Carta, Mauro Giovanni Kalcev, Goce Scano, Alessandra Pinna, Samantha Gonzalez, Cesar Ivan Aviles Nardi, Antonio Egidio Orrù, Germano Primavera, Diego Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures? |
title | Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures? |
title_full | Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures? |
title_fullStr | Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures? |
title_full_unstemmed | Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures? |
title_short | Screening, Genetic Variants, and Bipolar Disorders: Can Useful Hypotheses Arise from the Sum of Partial Failures? |
title_sort | screening, genetic variants, and bipolar disorders: can useful hypotheses arise from the sum of partial failures? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453758/ https://www.ncbi.nlm.nih.gov/pubmed/37623258 http://dx.doi.org/10.3390/clinpract13040077 |
work_keys_str_mv | AT cartamaurogiovanni screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures AT kalcevgoce screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures AT scanoalessandra screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures AT pinnasamantha screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures AT gonzalezcesarivanaviles screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures AT nardiantonioegidio screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures AT orrugermano screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures AT primaveradiego screeninggeneticvariantsandbipolardisorderscanusefulhypothesesarisefromthesumofpartialfailures |